経腸栄養剤市場-世界の産業規模、動向、機会、予測、2018～2028年、製品タイプ別、フロータイプ別、ステージ別、適応症別、最終用途別、地域別、競合

経腸栄養剤の世界市場は、2022年に58億9,000万米ドルの評価額に達し、予測期間においても着実な成長が見込まれ、年間平均成長率（CAGR）は6.81%と予測され、2028年には88億3,000万米ドルに達する見込みです。

世界の医療産業は大きな変革期を迎えており、包括的な患者ケアを重視する傾向が強まっています。栄養は患者の幸福にとって重要な側面であり、病状により経口摂取が困難な患者には、経腸栄養剤が不可欠なソリューションとして浮上しています。乳児用調製粉乳の世界市場は、未熟児から高齢者まで、回復と全身の健康に必要な重要栄養素を確実に摂取できるようにする上で極めて重要な役割を果たしています。

経腸栄養は、チューブを介して消化管に直接栄養を送り込むことを含みます。この方法は、嚥下障害、消化器系の問題、重篤な病気などの状態により、経口摂取に課題がある場合に採用されます。経腸栄養剤は、経腸栄養剤または経管栄養剤としても知られ、多量栄養素、ビタミン、ミネラルをバランスよく配合した特殊な液体溶液です。乳児用調製粉乳は、乳児から成人までのさまざまな患者グループの特定の栄養ニーズに適合するように設計されています。標準製剤、疾患特異的製剤、糖尿病や腎不全などの特定の病状に合わせた特殊製剤など、さまざまなタイプに分類することができます。

高齢化が進む世界人口は、さまざまな健康状態に陥りやすく、通常の食事に支障をきたすことがあります。このため、高齢者の栄養ニーズに合わせてカスタマイズされた経腸栄養剤の需要が高まっています。がん、神経疾患、胃腸疾患などの慢性疾患は、患者の固形食摂取能力に影響を及ぼすことが多いです。そのような場合、経腸栄養剤は必要な栄養素を供給する効果的な手段となります。粉ミルク組成の進歩、疾患特異的な粉ミルクの市場開拓、経管栄養法の革新により、市場は拡大しています。これらの開拓により、経腸栄養はより実行可能で効果的なものとなり、市場の成長に寄与しています。

主な市場促進要因

• 1.慢性疾患の有病率の上昇：慢性疾患は、罹患期間が長く、進行が遅いことが特徴であり、世界中で罹患率と死亡率の主な原因となっています。経腸栄養剤に対する需要の高まりは、慢性疾患の管理に不可欠な要素として浮上し、世界の経腸栄養剤市場の拡大を牽引しています。ライフスタイルの変化、都市化、高齢化、タバコの使用、不健康な食生活、運動不足、過度のアルコール摂取などの危険因子が、慢性疾患の急増に寄与しています。経腸栄養剤は経管栄養剤としても知られ、経口で十分な栄養素を摂取できない人に必要な栄養素を消化管に直接供給するように設計された栄養製品です。これらの製剤は、胃や腸に留置されたチューブを通して投与されるため、健康維持に必要な栄養素を確実に摂取することができます。
• 2.高齢化人口の増加：世界人口の高齢化が進み、高齢者の割合が増加するにつれ、世界の医療産業は新たな課題と機会に直面しています。この人口動態の変化に影響を受ける主要分野の一つが経腸栄養剤市場です。消化器系に直接栄養を供給する経腸栄養は、さまざまな健康状態により適切な栄養摂取が困難な高齢者の健康維持に欠かせないものとなっています。このため、高齢化社会のニーズを満たすために急速に拡大している分野である経腸栄養剤の世界市場が立ち上がりつつあります。

主な市場課題：

• 1.規制上のハードル：経腸栄養剤市場が直面する主な課題の1つは、複雑な規制状況です。国によって、経腸栄養剤の製造、表示、販売に関する規制や基準はさまざまです。メーカー各社は、製品が現地の法律を遵守しつつ、世界な品質基準を満たすよう、迷路のような規制を乗り越えなければならないです。これは経営の複雑さを増すだけでなく、市場で地位を確立しようとする新規参入者にとっても障壁となります。
• 2.コストの制約：経腸栄養剤は、主にその組成と製造工程が特殊であるため、通常の食品よりも高価であることが多いです。特に長期にわたる経腸栄養補給を必要とする患者にとって、このコストは大きな負担となりうる。さらに、医療プロバイダーや保険会社が費用対効果の高い選択肢を求めるため、コストの制約がメーカーの価格圧力につながることもあります。手頃な価格と質のバランスをとることは、メーカーと患者の双方にとって重要な課題となります。
• 3.栄養のカスタマイズ：経腸栄養を必要とする患者の栄養ニーズは、病状、年齢、全般的な健康状態に基づいて多様です。このような独自の要件を満たすようにカスタマイズできる処方を開発することは課題です。メーカーは研究開発に投資して、栄養バランスが取れているだけでなく、個々の患者に合わせた製品を開発する必要があります。生産効率と費用対効果を維持しながら、このレベルのカスタマイズを達成することは、微妙なバランスのとり方です。
• 4.限られた認識と教育：経腸栄養剤は患者のケアにおいて重要な役割を担っているにもかかわらず、医療専門家、患者、介護者の間では、認識や教育が限られていることが多いです。このような認識不足は、不適切な使用、誤った投与、不十分な栄養支持につながる可能性があります。医療専門家は、特定の患者のニーズに合った適切な処方を行うための十分な訓練を受けていない可能性があります。これらの製品の適切な利用を確保し、患者の転帰を改善するためには、教育および認識向上への取り組みが不可欠です。
• 5.競合とイノベーション：経腸栄養剤市場は競争が激しく、数多くのメーカーが市場シェアを争っています。この競争は技術革新を促進するが、同時に課題ももたらします。メーカーが差別化を図ろうとするあまり、その主張を裏付ける十分な臨床的証拠や調査がないまま製品を発売する危険性があります。技術革新と厳密な科学的検証のバランスをとることは、患者の安全を維持し、市場の健全性を維持するために極めて重要です。

主な市場動向：

• 1.技術の進歩：経腸栄養剤の分野における技術の進歩は、製品開発と投与方法に革命をもたらしました。技術革新により、さまざまな病状の患者の特定の栄養要件に対応するように設計された、高度に専門的で栄養学的に高度な経腸栄養剤の創出が可能になっています。正確な処方と生物活性成分の配合により、患者の回復と全体的な健康の向上に寄与しています。プログラム可能なポンプを含む最先端の送達システムは、正確な栄養送達を保証し、合併症を減らします。モノのインターネット（IoT）技術により、患者のデータをリアルタイムで送信するスマートな給餌ポンプや監視装置が登場し、臨床上の意思決定が強化されています。人工知能（AI）と機械学習アルゴリズムは、患者のデータに基づいて、オーダーメイドの栄養処方とスケジュールを推奨します。
• 2.セグメント別洞察- 製品別：2022年には、スタンダード・フォーミュラ・セグメントが市場を独占し、今後も拡大が続くと予測されます。標準経腸栄養剤は、幅広い患者の一般的な栄養ニーズを満たすように処方され、確立された栄養ガイドラインを遵守し、特定の食事制限や病状のないほとんどの患者に適した多量栄養素と微量栄養素のバランスの取れた組み合わせを提供します。安全性と有効性を裏付ける臨床エビデンスがあることから、医療プロバイダーにとって好ましい選択肢となっています。
• 3.セグメント別洞察-フロータイプ別：2022年には、間欠栄養フロー・セグメントが市場を独占し、今後も拡大が続くと予測されます。間欠栄養は、日中の特定の時間帯に栄養を供給することで、患者が栄養チューブを使用しない時間を長くすることを可能にします。これにより、継続的な栄養補給に比べて患者の快適性と耐容性が向上し、生活の質が向上し、自然な食事パターンに合わせることができます。

地域別洞察-北米：北米では高齢者人口が大幅に増加しています。高齢者は、加齢に関連した健康問題のために経腸栄養を必要とする可能性が高くなることが多いです。こうした需要が経腸栄養剤の成長に寄与しています。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 経腸栄養剤の世界市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 製品別（標準フォーミュラ、疾患特異的フォーミュラ）
  • フロータイプ別（間欠給餌フロー、連続給餌フロー）
  • ステージ別（成人、小児）
  • 適応症別（アルツハイマー、栄養不足、がん治療、糖尿病、慢性腎臓病、希少疾患、嚥下障害、疼痛管理、吸収不良/GI障害/下痢、その他）
  • エンドユーザー別（病院、在宅ケア）
  • 地域別
  • 企業別（主要5社シェア）
• 市場マップ
  • 製品別
  • フロータイプ別
  • ステージ別
  • 適応症別
  • 用途別
  • 地域別

第6章 北米の経腸栄養剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • フロータイプ別
  • ステージ別
  • 適応症別
  • 用途別
  • 国別

第7章 欧州の経腸栄養剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • フロータイプ別
  • ステージ別
  • 適応症別
  • 用途別
  • 国別

第8章 アジア太平洋の経腸栄養剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 製品別
  • フロータイプ別
  • ステージ別
  • 適応症別
  • 用途別
  • 国別

第9章 南米の経腸栄養剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • フロータイプ別
  • ステージ別
  • 適応症別
  • 用途別
  • 国別

第10章 中東・アフリカの経腸栄養剤市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • タイプ別
  • フロータイプ別
  • ステージ別
  • 適応症別
  • 用途別
  • 国別

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の展開
• 合併・買収
• 製品発表

第13章 競合情勢

• Abbott
• Danone S.A
• Fresenius Kabi AG
• Nestle
• VICTUS
• Primus Pharmaceuticals, Inc.
• Meiji Holdings. Co.,Ltd.
• Mead Johnson & Company, LLC

第14章 戦略的提言

第15章 調査会社について・免責事項

The Global Enteral Feeding Formulas Market reached a valuation of USD 5.89 Billion in 2022 and is expected to experience steady growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 6.81% and expected to reach USD 8.83 Billion by 2028. The global healthcare industry is undergoing a significant transformation, with a growing emphasis on comprehensive patient care. Nutrition is a critical aspect of patient well-being, and for individuals unable to consume food orally due to medical conditions, enteral feeding formulas have emerged as an essential solution. The Global Enteral Feeding Formulas Market plays a pivotal role in ensuring that individuals, ranging from premature infants to elderly patients, receive the vital nutrients required for recovery and overall health.

Enteral feeding involves delivering nutrients directly into the gastrointestinal tract via a tube. This method is employed when individuals face challenges in oral food consumption due to conditions like swallowing disorders, digestive issues, or critical illness. Enteral feeding formulas, also known as enteral nutrition or tube feeding formulas, are specialized liquid solutions containing a balanced mix of macronutrients, vitamins, and minerals. These formulas are designed to match the specific nutritional needs of different patient groups, spanning from infants to adults. They can be categorized into various types, including standard formulas, disease-specific formulas, and specialized formulations tailored to specific medical conditions such as diabetes or renal failure.

The aging global population is prone to various health conditions that can hinder their ability to eat normally. This has led to an increased demand for enteral feeding formulas customized to the nutritional needs of the elderly. Chronic conditions such as cancer, neurological disorders, and gastrointestinal diseases often affect a patient's capacity to consume solid food. In such cases, enteral feeding formulas provide an effective means of delivering essential nutrients. The market has expanded due to advancements in formula compositions, the development of disease-specific formulas, and innovations in tube-feeding techniques. These developments have made enteral nutrition more viable and effective, thereby contributing to market growth.

Key Market Drivers:

• 1. Rising Prevalence of Chronic Diseases: Chronic diseases, characterized by their long duration and slow progression, have become a leading cause of morbidity and mortality worldwide. The growing demand for enteral feeding formulas has emerged as a vital component in the management of chronic diseases, driving the expansion of the global enteral feeding formulas market. Lifestyle changes, urbanization, an aging population, and risk factors such as tobacco use, unhealthy diets, physical inactivity, and excessive alcohol consumption have contributed to the surge in chronic diseases. Enteral feeding formulas, also known as tube feeding formulas, are nutritional products designed to provide essential nutrients directly into the gastrointestinal tract for individuals who cannot consume sufficient nutrients orally. These formulas are administered through tubes placed in the stomach or intestines, ensuring that individuals receive the required nutrients to maintain their health and well-being.

• 2. Increasing Aging Population: As the world's population continues to age, with a growing proportion of elderly individuals, the global healthcare industry is facing new challenges and opportunities. One of the key areas impacted by this demographic shift is the enteral feeding formulas market. Enteral feeding, which involves providing nutrition directly into the digestive system, has become crucial for the well-being of elderly individuals who may struggle with proper nutrition intake due to various health conditions. This has led to the rise of the global enteral feeding formulas market, a sector that is rapidly expanding to meet the needs of an aging population.

Key Market Challenges:

• 1. Regulatory Hurdles: One of the primary challenges confronting the enteral feeding formulas market is the complex regulatory landscape. Different countries have varying regulations and standards governing the production, labeling, and marketing of these products. Manufacturers must navigate a maze of regulations to ensure their products comply with local laws while also meeting global quality standards. This not only increases operational complexity but also poses a barrier for new entrants looking to establish themselves in the market.

• 2. Cost Constraints: Enteral feeding formulas are often more expensive than regular food, primarily due to the specialized nature of their composition and production process. The cost can become a significant burden for patients, especially those requiring long-term enteral feeding solutions. Additionally, cost constraints may lead to pricing pressures for manufacturers as healthcare providers and insurers seek cost-effective options. Striking a balance between affordability and quality becomes a significant challenge for both manufacturers and patients.

• 3. Nutritional Customization: Patients requiring enteral feeding have diverse nutritional needs based on their medical condition, age, and overall health. Developing formulas that can be customized to meet these unique requirements is a challenge. Manufacturers need to invest in research and development to create products that are not only nutritionally balanced but can also be tailored to individual patients. Achieving this level of customization while maintaining production efficiency and cost-effectiveness can be a delicate balancing act.

• 4. Limited Awareness and Education: Despite the critical role enteral feeding formulas play in patient care, there is often limited awareness and education among healthcare professionals, patients, and caregivers. This lack of awareness can lead to improper usage, incorrect dosing, and inadequate nutritional support. Healthcare professionals may not be adequately trained to prescribe the right formula for specific patient needs. Increasing education and awareness efforts are essential to ensure proper utilization of these products and improve patient outcomes.

• 5. Competition and Innovation: The enteral feeding formulas market is competitive, with numerous manufacturers vying for market share. This competition can drive innovation, but it also presents challenges. As manufacturers strive to differentiate themselves, there is a risk of introducing products without sufficient clinical evidence or research to support their claims. Balancing innovation with rigorous scientific validation is crucial to maintain patient safety and uphold the integrity of the market.

Key Market Trends:

• 1. Technological Advancements: Technological advancements in the field of enteral feeding formulas have revolutionized product development and administration methods. Innovations have enabled the creation of highly specialized and nutritionally advanced enteral feeding formulas designed to cater to the specific nutritional requirements of patients with various medical conditions. Precise formulation and the inclusion of bioactive ingredients contribute to better patient recovery and overall health. Cutting-edge delivery systems, including programmable pumps, ensure precise nutrient delivery, reducing complications. Internet of Things (IoT) technology has led to smart feeding pumps and monitoring devices that transmit real-time patient data, enhancing clinical decision-making. Artificial intelligence (AI) and machine learning algorithms recommend tailored feeding formulas and schedules based on patient data.

• 2. Segmental Insights - Product: In 2022, the Standard Formula segment dominated the market and is predicted to continue expanding. Standard enteral feeding formulas are formulated to meet the general nutritional needs of a wide range of patients, adhering to established nutritional guidelines and offering a balanced combination of macronutrients and micronutrients suitable for most patients without specific dietary restrictions or medical conditions. The availability of clinical evidence supporting their safety and efficacy makes them a preferred choice for healthcare providers.

• 3. Segmental Insights - Flow Type: In 2022, the Intermittent Feeding Flow segment dominated the market and is predicted to continue expanding. Intermittent feeding involves providing nutrients over specific periods during the day, allowing patients to have longer periods without the feeding tube in use. This can improve patient comfort and tolerance compared to continuous feeding, enhancing quality of life and aligning with natural eating patterns.

Regional Insights - North America: The North American population is experiencing a significant increase in the elderly population. Elderly individuals often have a higher likelihood of requiring enteral nutrition due to age-related health issues. This demand has contributed to the growth of the enteral

feeding formulas market in the region. North America, particularly the United States, possesses a well-developed and sophisticated healthcare infrastructure, ensuring easy access to enteral feeding formulas for patients in need. The region also sees a high prevalence of chronic diseases, further driving demand for these products.

Key Market Players

• Abbott
• Danone S.A
• Fresenius Kabi AG
• Nestle
• VICTUS
• Primus Pharmaceuticals, Inc.
• Meiji Holdings. Co.,Ltd.
• Mead Johnson & Company, LLC

Report Scope:

• In this report, the Global Enteral Feeding Formulas Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Enteral Feeding Formulas Market, By Product:

• Standard Formula
• Disease-specific Formulas

Enteral Feeding Formulas Market, By Flow Type:

• Intermittent Feeding Flow
• Continuous Feeding Flow

Enteral Feeding Formulas Market, By Stage:

• Adults
• Pediatrics

Enteral Feeding Formulas Market, By Indication:

• Adults
• Alzheimer's
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia, Pain Management
• Malabsorption/GI Disorder/Diarrhea
• Others

Enteral Feeding Formulas Market, By End-User:

• Hospitals
• Homecare

Enteral Feeding Formulas Market, By Region:

• North America
• Asia-Pacific
• Europe
• Middle East & Africa
• South America

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Enteral Feeding Formulas Market.

Available Customizations:

• Global Enteral Feeding Formulas Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Enteral Feeding Formulas Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Standard Formula, Disease-specific Formulas)
  • 5.2.2. By Flow Type (Intermittent Feeding Flow, Continuous Feeding Flow)
  • 5.2.3. By Stage ( Adults, Pediatrics)
  • 5.2.4. By Indication (Alzheimer's, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others)
  • 5.2.5. By End-Use (Hospitals, Homecare)
  • 5.2.6. By Region
  • 5.2.7. By Company (Shares of Top 5 Market Players)
• 5.3. Market Map
  • 5.3.1. By Product
  • 5.3.2. By Flow Type
  • 5.3.3. By Stage
  • 5.3.4. By Indication
  • 5.3.5. By End-Use
  • 5.3.6. By Region

6. North America Enteral Feeding Formulas Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Flow Type
  • 6.2.3. By Stage
  • 6.2.4. By Indication
  • 6.2.5. By End-Use
  • 6.2.6. By Country
    • 6.2.6.1. United States Enteral Feeding Formulas Market Outlook
      • 6.2.6.1.1. Market Size & Forecast
      • 6.2.6.1.1.1. By Value
      • 6.2.6.1.2. Market Share & Forecast
      • 6.2.6.1.2.1. By Product
      • 6.2.6.1.2.2. By Flow Type
      • 6.2.6.1.2.3. By Stage
      • 6.2.6.1.2.4. By Indication
      • 6.2.6.1.2.5. By End-Use
    • 6.2.6.2. Canada Enteral Feeding Formulas Market Outlook
      • 6.2.6.2.1. Market Size & Forecast
      • 6.2.6.2.1.1. By Value
      • 6.2.6.2.2. Market Share & Forecast
      • 6.2.6.2.2.1. By Product
      • 6.2.6.2.2.2. By Flow Type
      • 6.2.6.2.2.3. By Stage
      • 6.2.6.2.2.4. By Indication
      • 6.2.6.2.2.5. By End-Use
    • 6.2.6.3. Mexico Enteral Feeding Formulas Market Outlook
      • 6.2.6.3.1. Market Size & Forecast
      • 6.2.6.3.1.1. By Value
      • 6.2.6.3.2. Market Share & Forecast
      • 6.2.6.3.2.1. By Test
      • 6.2.6.3.2.2. By Flow Type
      • 6.2.6.3.2.3. By Stage
      • 6.2.6.3.2.4. By Indication
      • 6.2.6.3.2.5. By End-Use

7. Europe Enteral Feeding Formulas Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Flow Type
  • 7.2.3. By Stage
  • 7.2.4. By Indication
  • 7.2.5. By End-Use
  • 7.2.6. By Country
    • 7.2.6.1. France Enteral Feeding Formulas Market Outlook
      • 7.2.6.1.1. Market Size & Forecast
      • 7.2.6.1.1.1. By Value
      • 7.2.6.1.2. Market Share & Forecast
      • 7.2.6.1.2.1. By Product
      • 7.2.6.1.2.2. By Flow Type
      • 7.2.6.1.2.3. By Stage
      • 7.2.6.1.2.4. By Indication
      • 7.2.6.1.2.5. By End-Use
    • 7.2.6.2. Germany Enteral Feeding Formulas Market Outlook
      • 7.2.6.2.1. Market Size & Forecast
      • 7.2.6.2.1.1. By Value
      • 7.2.6.2.2. Market Share & Forecast
      • 7.2.6.2.2.1. By Product
      • 7.2.6.2.2.2. By Flow Type
      • 7.2.6.2.2.3. By Stage
      • 7.2.6.2.2.4. By Indication
      • 7.2.6.2.2.5. By End-Use
    • 7.2.6.3. United Kingdom Enteral Feeding Formulas Market Outlook
      • 7.2.6.3.1. Market Size & Forecast
      • 7.2.6.3.1.1. By Value
      • 7.2.6.3.2. Market Share & Forecast
      • 7.2.6.3.2.1. By Product
      • 7.2.6.3.2.2. By Flow Type
      • 7.2.6.3.2.3. By Stage
      • 7.2.6.3.2.4. By Indication
      • 7.2.6.3.2.5. By End-Use
    • 7.2.6.4. Italy Enteral Feeding Formulas Market Outlook
      • 7.2.6.4.1. Market Size & Forecast
      • 7.2.6.4.1.1. By Value
      • 7.2.6.4.2. Market Share & Forecast
      • 7.2.6.4.2.1. By Product
      • 7.2.6.4.2.2. By Flow Type
      • 7.2.6.4.2.3. By Stage
      • 7.2.6.4.2.4. By Indication
      • 7.2.6.4.2.5. By End-Use
    • 7.2.6.5. Spain Enteral Feeding Formulas Market Outlook
      • 7.2.6.5.1. Market Size & Forecast
      • 7.2.6.5.1.1. By Value
      • 7.2.6.5.2. Market Share & Forecast
      • 7.2.6.5.2.1. By Product
      • 7.2.6.5.2.2. By Flow Type
      • 7.2.6.5.2.3. By Stage
      • 7.2.6.5.2.4. By Indication
      • 7.2.6.5.2.5. By End-Use

8. Asia Pacific Enteral Feeding Formulas Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Flow Type
  • 8.2.3. By Stage
  • 8.2.4. By Indication
  • 8.2.5. By End-Use
  • 8.2.6. By Country
    • 8.2.6.1. China Enteral Feeding Formulas Market Outlook
      • 8.2.6.1.1. Market Size & Forecast
      • 8.2.6.1.1.1. By Value
      • 8.2.6.1.2. Market Share & Forecast
      • 8.2.6.1.2.1. By Product
      • 8.2.6.1.2.2. By Flow Type
      • 8.2.6.1.2.3. By Stage
      • 8.2.6.1.2.4. By Indication
      • 8.2.6.1.2.5. By End-Use
    • 8.2.6.2. India Enteral Feeding Formulas Market Outlook
      • 8.2.6.2.1. Market Size & Forecast
      • 8.2.6.2.1.1. By Value
      • 8.2.6.2.2. Market Share & Forecast
      • 8.2.6.2.2.1. By Product
      • 8.2.6.2.2.2. By Flow Type
      • 8.2.6.2.2.3. By Stage
    • 8.2.6.3. South Korea Enteral Feeding Formulas Market Outlook
      • 8.2.6.3.1. Market Size & Forecast
      • 8.2.6.3.1.1. By Value
      • 8.2.6.3.2. Market Share & Forecast
      • 8.2.6.3.2.1. By Product
      • 8.2.6.3.2.2. By Flow Type
      • 8.2.6.3.2.3. By Stage
      • 8.2.6.3.2.4. By Indication
      • 8.2.6.3.2.5. By End-Use
    • 8.2.6.4. Japan Enteral Feeding Formulas Market Outlook
      • 8.2.6.4.1. Market Size & Forecast
      • 8.2.6.4.1.1. By Value
      • 8.2.6.4.2. Market Share & Forecast
      • 8.2.6.4.2.1. By Product
      • 8.2.6.4.2.2. By Flow Type
      • 8.2.6.4.2.3. By Stage
      • 8.2.6.4.2.4. By Indication
      • 8.2.6.4.2.5. By End-Use
    • 8.2.6.5. Australia Enteral Feeding Formulas Market Outlook
      • 8.2.6.5.1. Market Size & Forecast
      • 8.2.6.5.1.1. By Value
      • 8.2.6.5.2. Market Share & Forecast
      • 8.2.6.5.2.1. By Product
      • 8.2.6.5.2.2. By Flow Type
      • 8.2.6.5.2.3. By Stage
      • 8.2.6.5.2.4. By Indication
      • 8.2.6.5.2.5. By End-Use

9. South America Enteral Feeding Formulas Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Flow Type
  • 9.2.3. By Stage
  • 9.2.4. By Indication
  • 9.2.5. By End-Use
  • 9.2.6. By Country
    • 9.2.6.1. Brazil Enteral Feeding Formulas Market Outlook
      • 9.2.6.1.1. Market Size & Forecast
      • 9.2.6.1.1.1. By Value
      • 9.2.6.1.2. Market Share & Forecast
      • 9.2.6.1.2.1. By Product
      • 9.2.6.1.2.2. By Flow Type
      • 9.2.6.1.2.3. By Stage
    • 9.2.6.2. Argentina Enteral Feeding Formulas Market Outlook
      • 9.2.6.2.1. Market Size & Forecast
      • 9.2.6.2.1.1. By Value
      • 9.2.6.2.2. Market Share & Forecast
      • 9.2.6.2.2.1. By Product
      • 9.2.6.2.2.2. By Flow Type
      • 9.2.6.2.2.3. By Stage
      • 9.2.6.2.2.4. By Indication
      • 9.2.6.2.2.5. By End-Use
    • 9.2.6.3. Colombia Enteral Feeding Formulas Market Outlook
      • 9.2.6.3.1. Market Size & Forecast
      • 9.2.6.3.1.1. By Value
      • 9.2.6.3.2. Market Share & Forecast
      • 9.2.6.3.2.1. By Product
      • 9.2.6.3.2.2. By Flow Type
      • 9.2.6.3.2.3. By Stage
      • 9.2.6.3.2.4. By Indication
      • 9.2.6.3.2.5. By End-Use

10. Middle East & Africa Enteral Feeding Formulas Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Flow Type
  • 10.2.3. By Stage
  • 10.2.4. By Indication
  • 10.2.5. By End-Use
  • 10.2.6. By Country
    • 10.2.6.1. South Africa Enteral Feeding Formulas Market Outlook
      • 10.2.6.1.1. Market Size & Forecast
      • 10.2.6.1.1.1. By Value
      • 10.2.6.1.2. Market Share & Forecast
      • 10.2.6.1.2.1. By Product
      • 10.2.6.1.2.2. By Flow Type
      • 10.2.6.1.2.3. By Stage
    • 10.2.6.2. Saudi Arabia Enteral Feeding Formulas Market Outlook
      • 10.2.6.2.1. Market Size & Forecast
      • 10.2.6.2.1.1. By Value
      • 10.2.6.2.2. Market Share & Forecast
      • 10.2.6.2.2.1. By Product
      • 10.2.6.2.2.2. By Flow Type
      • 10.2.6.2.2.3. By Stage
      • 10.2.6.2.2.4. By Indication
      • 10.2.6.2.2.5. By End-Use
    • 10.2.6.3. UAE Enteral Feeding Formulas Market Outlook
      • 10.2.6.3.1. Market Size & Forecast
      • 10.2.6.3.1.1. By Value
      • 10.2.6.3.2. Market Share & Forecast
      • 10.2.6.3.2.1. By Product
      • 10.2.6.3.2.2. By Flow Type
      • 10.2.6.3.2.3. By Stage
      • 10.2.6.3.2.4. By Indication
      • 10.2.6.3.2.5. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Competitive Landscape

• 13.1. Abbott
• 13.2. Danone S.A
• 13.3. Fresenius Kabi AG
• 13.4. Nestle
• 13.5. VICTUS
• 13.6. Primus Pharmaceuticals, Inc.
• 13.7. Meiji Holdings. Co.,Ltd.
• 13.8. Mead Johnson & Company, LLC

14. Strategic Recommendations

15. About us & Disclaimer